Gideon Kersten
Impact in
- Pharmaceutical Science top 0.1%
- Advancements in Transdermal Drug Delivery
- Advanced Drug Delivery Systems
- Microbiology top 0.5%
- Bacterial Infections and Vaccines
Papers in
- Immunology 49
- Immunotherapy and Immune Responses 22
- Toxin Mechanisms and Immunotoxins 20
-
- Protein purification and stability 13
- Co-authors
- Wim Jiskoot (50 shared papers)Daan J.A. Crommelin (19 shared papers)Jean‐Pierre Amorij (26 shared papers)Joke A. Bouwstra (22 shared papers)Rein Verbeke (1 shared paper)Linde Schoenmaker (1 shared paper)Dominik Witzigmann (1 shared paper)Jayesh A. Kulkarni (1 shared paper)
- Journals
- Vaccine (25 papers)Journal of Controlled Release (9 papers)Pharmaceutical Research (9 papers)PLoS ONE (7 papers)Biologicals (7 papers)
- Partner nations
- NetherlandsUnited StatesGuinea-Bissau
In The Last Decade
Gideon Kersten
124 papers receiving 6.3k citations
Gideon Kersten's Hit Papers
Peers
Comparison fields: 5 of 149
- Pharmaceutical Science 1.6k
- Microbiology 693
- Immunology 1.7k
- Dermatology 548
- Infectious Diseases 969
Countries citing papers authored by Gideon Kersten
This map shows the geographic impact of Gideon Kersten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gideon Kersten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gideon Kersten more than expected).
Fields of papers citing papers by Gideon Kersten
This network shows the impact of papers produced by Gideon Kersten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gideon Kersten. The network helps show where Gideon Kersten may publish in the future.
Co-authors
The 25 scholars most cited alongside Gideon Kersten, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 125 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability Hit paper breakdown → | 2021 | 1093 |
| 2 | 2004 | 494 | |
| 3 | 2015 | 235 | |
| 4 | 2003 | 192 | |
| 5 | 2017 | 176 | |
| 6 | 2014 | 163 | |
| 7 | 2006 | 161 | |
| 8 | 2015 | 122 | |
| 9 | 1995 | 121 | |
| 10 | 2003 | 118 | |
| 11 | 2009 | 117 | |
| 12 | 2015 | 97 | |
| 13 | 1991 | 82 | |
| 14 | 2012 | 81 | |
| 15 | 2015 | 79 | |
| 16 | 2011 | 74 | |
| 17 | 2017 | 73 | |
| 18 | 2015 | 71 | |
| 19 | 2014 | 71 | |
| 20 | 2009 | 70 |
About Gideon Kersten
Gideon Kersten is a scholar working on Immunology, Molecular Biology, Epidemiology, Pharmaceutical Science and Microbiology, having authored 125 papers that have together received 6.5k indexed citations. Recurring topics across this work include Advancements in Transdermal Drug Delivery (25 papers), Bacterial Infections and Vaccines (23 papers), Immunotherapy and Immune Responses (22 papers), Toxin Mechanisms and Immunotoxins (20 papers), Viral Infections and Immunology Research (18 papers), Monoclonal and Polyclonal Antibodies Research (17 papers), Influenza Virus Research Studies (15 papers) and Protein purification and stability (13 papers). The work is most often cited by research in Pharmaceutical Science (1.6k citations), Microbiology (693 citations), Immunology (1.7k citations), Dermatology (548 citations) and Infectious Diseases (969 citations). Gideon Kersten has collaborated with scholars based in Netherlands, United States and Guinea-Bissau. Frequent co-authors include Wim Jiskoot, Daan J.A. Crommelin, Jean‐Pierre Amorij, Joke A. Bouwstra, Rein Verbeke, Linde Schoenmaker, Dominik Witzigmann, Jayesh A. Kulkarni, Bernard Metz and Peter C. Soema. Their work appears in journals such as Vaccine, Journal of Controlled Release, Pharmaceutical Research, PLoS ONE and Biologicals.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.